FIELD: medicine, infectious diseases. SUBSTANCE: method involves oral administration of lamivudine in the dose 100-150 mg for 12 months additionally to the conventional therapy to patients with light or middle- -severe forms of acute viral hepatitis B. Invention prevents the process synchronization and promotes to reduction of adverse symptoms in treatment of patients with light and middle- severe forms of acute viral hepatitis B. Invention can be used for treatment of acute viral hepatitis B. EFFECT: enhanced effectiveness of treatment.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING EFFECTIVENESS OF MAGNETOTHERAPY APPLIED TO VIRAL HEPATITIS PATIENTS | 1997 |
|
RU2132556C1 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
METHOD FOR PREDICTION OF IF THERAPY EFFECTIVENESS FOR VIRAL HEPATITIS IN CHILDREN | 2008 |
|
RU2379689C1 |
METHOD OF FORECASTING FAST PROGRESSION OF DISEASE IN PATIENTS SUFFERING FROM CHRONIC HEPATITIS C | 2007 |
|
RU2354975C1 |
METHOD FOR FAST ASSESSMENT OF DEGREE OF ACTIVITY OF CHRONIC HEPATITIS IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2469326C1 |
METHOD FOR DIAGNOSING MYASTHENIA | 1994 |
|
RU2098106C1 |
METHOD FOR RAPID ASSESSMENT OF DEGREE OF ACTIVITY OF CHRONIC HEPATITIS C IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2474817C1 |
METHOD OF TREATMENT PATIENTS FOR VIRUS HEPATITIS | 0 |
|
SU1806777A1 |
METHOD OF EARLY DIAGNOSIS OF SEVERE FORM OF VIRAL HEPATITIS B | 0 |
|
SU1767428A1 |
METHOD FOR TREATING THE CASES OF ACUTE VIRUS HEPATITIS | 1998 |
|
RU2152815C1 |
Authors
Dates
2003-06-27—Published
2001-06-20—Filed